Lactoferrin Market Size
Global Lactoferrin Market reached US$ 450.10 million in 2025 and is projected to witness lucrative growth by reaching up to US$ 762.00 million by 2033. The market is growing at a CAGR of 7.4% during the forecast period 2026-2033. The need for natural and beneficial ingredients in food, beverages, and dietary supplements is rising.
Since lactoferrin is a naturally occurring bioactive protein, it fits with this trend. In order to provide health advantages and satisfy customer desire for natural and useful ingredients, more and more products are being developed that use lactoferrin.
Due to its potential advantages for newborn health, lactoferrin is increasingly being included in infant formula. Manufacturers are using lactoferrin to improve the nutritional profile and offer immunological support as they work to create baby formula products that closely mimic breast milk. Infant formula products that are lactoferrin-fortified are becoming more and more prevalent on the market.
Lactoferrin Market Scope
| Metrics | Details |
| CAGR | 7.4% |
| Size Available for Years | 2025-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Source, Application, End-Use, and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
To Know More Insights - Download Sample
Lactoferrin Market Dynamics
Growing Demand for Infant Formula Driving the Growth of the Lactoferrin Market
Lactoferrin naturally occurs in breast milk and plays a vital role in infant nutrition. It provides numerous benefits to infants, including immune modulation, antimicrobial activities, and intestinal health. According to CDC, early one in five babies receive formula within their first two days of life. As more infants are fed with formula instead of breast milk, there is a need to enhance the nutritional profile of infant formula. Lactoferrin is considered an essential component in the formulation of high-quality infant formula to provide these important health benefits.
Breast milk is the optimal source of nutrition for infants due to its unique composition that promotes healthy growth and development. Lactoferrin is a bioactive protein found in breast milk, and its inclusion in infant formula helps to mimic the composition of breast milk more closely. Manufacturers are incorporating lactoferrin into infant formula to provide a more comprehensive nutritional profile that resembles breast milk.
The Rising Prevalence of Skin Diseases is Driving the Growth of the Lactoferrin Market
Skin disorders are among the most common ailments in the world, and their incidence is rising. Acne affects nearly 50 million Americans each year, according to the American Academy of Dermatology Association, with moderate acne impacting 85 percent of those aged 12 to 24. With acne being one of the most frequent skin problems among teens, the need for lactoferrin in acne treatments is increasing.
According to a study published in the National Library of Medicine, using lactoferrin for 12 weeks reduces inflammatory lesion count by 38.6%, overall lesion count by 23.1%, and acne grade by 20.3% compared to the placebo group. Lactoferrin is so frequently employed in wound healing and dermal immune response decrease by stimulating connective tissue with epidermal cells and repairing the skin.
High Cost of Lactoferrin Can Restrain the Growth of the Lactoferrin Market
The primary natural sources of lactoferrin are bovine milk and human milk. However, compared to the total need for lactoferrin, the supply from these sources is inadequate. Due to the restricted supply, obtaining sufficient amounts of lactoferrin may need specialized sourcing and processing techniques, which might increase the cost of raw materials.
Supplements, functional foods, and baby formula that include lactoferrin may have higher pricing due to the high cost of lactoferrin manufacture. This may make certain goods more expensive for some customers, resulting in a decline in demand and possible market restrictions.
Lactoferrin Market Segment Analysis
The global lactoferrin market is segmented based on source, application, end-use, and region.
Lactoferrin is Popular in Infant Formulae Because of its Nutritional Content Being Similar to Breastmilk along with Antibacterial Properties
The global lactoferrin market has been segmented by end-use into functional foods & drinks, dietary supplements, infant formula, cosmetics, and others
In 2022, infant formula had the highest revenue share in the lactoferrin market. Infant formula frequently contains lactoferrin. Infants' growth is significantly impacted by lactoferrin's antibacterial, anti-inflammatory, and immunomodulator capabilities, which have also been linked to the development of the neurological system. Numerous studies have demonstrated that lactoferrin, particularly that from cows, is crucial for gut flora and increases resistance to infections.
Lactoferrin has particularly showed a favourable effect on underweight neonates since it lowers the incidence of delayed-onset septicemia (bacterial or fungal). The need for lactoferrin in newborn formulae has grown as a result of all these causes. As baby food producers work to give newborns nutrition that is comparable to that found in breast milk, the inclusion of lactoferrin in infant formula maintains the growth of the lactoferrin market. For instance, in response to the rising demand for newborn nourishment, Friesland Campina stated in September 2020 that it is boosting its lactoferrin production capacity in the Netherlands.
Source: DataM Intelligence Analysis (2023)
Global Lactoferrin Market Geographical Share
Growing Population Preferences in Asia-Pacific Region
In 2022, Asia -Pacific had the highest revenue share of the lactoferrin market with the majority of babies getting supplemented with infant formula belonging to the Asia-Pacific. China and India are the two most populous countries in the Asia and Pacific area, which has 4.3 billion people, or 60% of the world's population, according to the United Nations Population Fund. Due to the high birth rate in this area, there is a high need for baby-feeding products, such as lactoferrin.
Moreover, with increasing literacy rate coupled with rising consumer awareness regarding infant nutrition, personal care, and pharmaceutical products along with consumer inclination toward organic products is expected to drive the growth. China accounts for the majority of the shares of the market, due to the lowest breastfeeding rates in the country. The abandonment of one child policy has especially contributed to the rising demand for infant formula.
Source: DataM Intelligence Analysis (2023)
Lactoferrin Market Companies
The major global players include MILEI GmbH, Farbest Brands, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputa Dairy Australia Pty Ltd., Forterra Co-Operative Group, Armor Proteins, Hilmar Cheese Company, Inc., Conagen, Inc.
By Source
- Bovine Milk
- Engineered Rice
- Porcine Milk
- Human Milk
- Murine Milk
- Others
By Application
- Immune Health
- Oral Hygiene
- Gut Health
- Skincare
- Others
By End-Use
- Functional Foods & Drinks
- Dietary Supplements
- Infant Formula
- Cosmetics
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
- On April 18, 2026, Fonterra Co-operative Group announced expansion of its lactoferrin production capabilities in New Zealand to meet rising global demand from infant nutrition and immune health supplement manufacturers. The expansion focuses on improving extraction efficiency and scaling high-purity lactoferrin supply for premium nutrition applications across Asia-Pacific and North America.
- On January 30, 2026, FrieslandCampina strengthened its lactoferrin innovation pipeline by advancing next-generation purification technologies aimed at enhancing bioactive protein stability for use in infant formula and clinical nutrition products. The company highlighted increasing demand for immune-supporting ingredients as a key growth driver.
- On October 9, 2025, Glanbia plc expanded its bioactive dairy ingredients portfolio by increasing investment in lactoferrin-based functional nutrition solutions targeting sports nutrition, immunity support, and maternal health segments. The initiative supports rising demand for high-value dairy-derived bioactives in global nutraceutical markets.
- On August 22, 2025, Synlait Milk Ltd entered a strategic supply agreement with infant formula manufacturers to scale lactoferrin-enriched ingredients production. The company emphasized strong growth in demand for human milk–like bioactive proteins and premium infant nutrition formulations.
Why Purchase the Report?
- To visualize the global lactoferrin market segmentation based on source, application, end-use, and region understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous lactoferrin market-level data points all for segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The Global Lactoferrin Market Report Would Provide Approximately 61 Tables, 64 Figures, and 102 Pages.
Target Audience 2026
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
